Regeneron, Bayer’s Eylea ‘to remain king’ as analysts see ‘tepid’ response to biosimilar threats February 24, 2022 Auto Bot News 0 Regeneron, Bayer’s Eylea ‘to remain king’ as analysts see ‘tepid’ response to biosimilar threats badams Thu, 02/24/2022 – 08:30
